Business

Mainstreet Equity Corp. Announces Quarterly Dividend for Period Ending September 30, 2026

Financial Post · October 9, 2026 at 7:08 a.m.

CALGARY, Alberta -- Mainstreet Equity Corp. (TSX: MEQ) today announces that the Board of Directors of Mainstreet Equity Corp. (Mainstreet) declared a quarterly cash dividend of $0.08 per Common Share of Mainstreet for the quarter ending September 30, 2026.

The dividend is payable on October 30, 2026 to shareholders of record at the close of business on October 17, 2026.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Mainstreet Equity Corp. Announces Quarterly Dividend for Period Ending September 30, 2026

More from Financial Post

Duncan Solutions Completes Transition to Standalone Tech- and AI-Enabled, End-to-End Transportation Revenue Cycle Management Platform

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity

Posthaste: Data centre anger is boiling over in Canada and here’s where opposition is highest

More in Business

Duncan Solutions Completes Transition to Standalone Tech- and AI-Enabled, End-to-End Transportation Revenue Cycle Management Platform

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity

Posthaste: Data centre anger is boiling over in Canada and here’s where opposition is highest

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care